July 17 2020, David R Brown
Azelis enters Israel with the acquisition of Orokia
Azelis, a leading distributor of specialty chemicals and food ingredients, has signed an agreement to acquire Orokia Israel Ltd ('Orokia'), a specialty chemicals distributor in Israel. Formed in 2005, Orokia represents blue chip principals and serves industries such as agrochemicals, animal nutrition, personal care, food, pharmaceuticals and industrial chemicals. Orokia employees will all move to Azelis.
This acquisition will bring an abundance of cross-selling opportunities to expand the business with our existing long-standing and trusted partnersAnna Bertona
CEO & President, Azelis EMEA
With the acquisition of Orokia Azelis enters into a highly attractive market that will allow it to expand its global coverage and serve the local Israeli market. The deal complements Azelis' acqusiition of the Orkila Group in 2019 which gave them a leading position specialty chemicals distribution in the Middle East and Africa. The addition of Orokia is expected to deliver a number of synergies including cross-selling opportunities to expand the business with Azelis' existing partners.
Anna Bertona, CEO & President, Azelis EMEA, remarked: “Orokia, and its forerunners, have been present in the Israeli market for almost four decades, during which time the company has built up a strong market presence, counting major global players among the principals represented and serving more than 200 customers.”
Liliane Halimi, Managing Director at Orokia, adds: “Becoming part of a strong international player such as Azelis will bring considerable added value to our offering in the local market, especially in our core areas of application and formulation support, which are pivotal to success in specialty chemicals. We will also benefit from Azelis' strong international infrastructure and access to additional customers and suppliers.”
Azelis is a leading distributor of specialty chemicals and food ingredients present in over 50 countries across the globe with around 2,200 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to about 40,000 customers, creating a turnover of €2.15 billion (2019).
Source(s): Azelis Press Release